Study of TKI258 Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Sponsors and Collaborators

Novartis Pharmaceuticals

 
Contact

Novartis Pharmaceuticals

+1 800 340 6843
 
Investigators

Novartis Pharmaceuticals


Continue Reading

Novartis Pharmaceuticals
  

ClinicalTrials.gov Identifier

NCT01223027